Home > Healthcare > Pharmaceuticals > Vaccines > Combination Vaccines Market

Combination Vaccines Market Size

Report ID: GMI6086
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Combination Vaccines Market Size

Combination Vaccines Market size was valued at USD 4.6 billion in 2022 and is anticipated to expand at over 10.9% CAGR from 2023 to 2032 driven by growing emphasis on preventive healthcare globally, with a focus on vaccination as a crucial preventive measure. The global market for vaccines is projected to reach USD 96.3 billion during the forecast period.

To get key market trends

Download Free Sample

The combination vaccines offer a comprehensive approach by providing protection against multiple diseases in a single shot. This convenience improves patient compliance and increases vaccination rates, thereby supplementing the industry growth. Additionally, increasing government initiatives such as funding, awareness campaigns, and vaccination mandates will drive the combination vaccines market demand.

Combination Vaccines Market Report Attributes
Report Attribute	Details
Base Year:	2022
Combination Vaccines Market Size in 2022:	USD 4.6 Billion
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	10.9%
2032 Value Projection:	USD 12.5 Billion
Historical Data for:	2018 to 2022
No. of Pages:	220
Tables, Charts & Figures:	336
Segments covered:	Age Group, Technology, Application, End-use, and Region
Growth Drivers:	Increasing prevalence of infectious diseases Rising focus on preventive healthcare Enhance vaccine coverage and improved patient compliance
Pitfalls & Challenges:	Stringent regulatory requirements High development and product costs

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of combination vaccines was worth USD 4.6 billion in 2022 and is projected to register 10.9% CAGR from 2023 to 2032 attributed to the increasing emphasis on preventive healthcare globally along with the rising focus on vaccination as a crucial preventive measure.

Combination vaccines industry size from the conjugate technology segment is estimated to cross USD 5.1 billion by 2032 owing to the massive R&D investments by pharmaceutical companies and government organizations.

North America held 40.8% of the global industry share in 2022 and is anticipated to exhibit robust growth till 2032 driven by the presence of favorable regulatory environment and the high prevalence of infectious diseases across the region.

Leading combination vaccines companies are Sanofi Pasteur, GlaxoSmithKline (GSK), Merck & Co., Inc., Panacea Biotec, Sinovac Biotech, and Serum Institute of India, among others.